CVS Health Goodwill and Intangible Assets 2010-2025 | CVS
CVS Health goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- CVS Health goodwill and intangible assets for the quarter ending March 31, 2025 were $117.773B, a 1.89% decline year-over-year.
- CVS Health goodwill and intangible assets for 2024 were $118.595B, a 1.59% decline from 2023.
- CVS Health goodwill and intangible assets for 2023 were $120.506B, a 17.05% increase from 2022.
- CVS Health goodwill and intangible assets for 2022 were $102.953B, a 4.8% decline from 2021.
| CVS Health Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $118,595 |
| 2023 | $120,506 |
| 2022 | $102,953 |
| 2021 | $108,147 |
| 2020 | $110,694 |
| 2019 | $112,870 |
| 2018 | $115,202 |
| 2017 | $52,081 |
| 2016 | $51,760 |
| 2015 | $51,984 |
| 2014 | $37,916 |
| 2013 | $36,071 |
| 2012 | $36,148 |
| 2011 | $36,327 |
| 2010 | $35,453 |
| 2009 | $35,807 |
| CVS Health Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $117,773 |
| 2024-12-31 | $118,595 |
| 2024-09-30 | $119,089 |
| 2024-06-30 | $119,583 |
| 2024-03-31 | $120,042 |
| 2023-12-31 | $120,506 |
| 2023-09-30 | $120,885 |
| 2023-06-30 | $121,378 |
| 2023-03-31 | $110,425 |
| 2022-12-31 | $102,953 |
| 2022-09-30 | $103,243 |
| 2022-06-30 | $106,695 |
| 2022-03-31 | $107,603 |
| 2021-12-31 | $108,147 |
| 2021-09-30 | $108,666 |
| 2021-06-30 | $109,632 |
| 2021-03-31 | $110,191 |
| 2020-12-31 | $110,694 |
| 2020-09-30 | $111,276 |
| 2020-06-30 | $112,282 |
| 2020-03-31 | $112,720 |
| 2019-12-31 | $112,870 |
| 2019-09-30 | $113,203 |
| 2019-06-30 | $113,648 |
| 2019-03-31 | $114,222 |
| 2018-12-31 | $115,202 |
| 2018-09-30 | $47,382 |
| 2018-06-30 | $47,542 |
| 2018-03-31 | $51,503 |
| 2017-12-31 | $52,081 |
| 2017-09-30 | $51,472 |
| 2017-06-30 | $51,484 |
| 2017-03-31 | $51,653 |
| 2016-12-31 | $51,760 |
| 2016-09-30 | $51,781 |
| 2016-06-30 | $51,829 |
| 2016-03-31 | $51,865 |
| 2015-12-31 | $51,984 |
| 2015-09-30 | $50,639 |
| 2015-06-30 | $37,805 |
| 2015-03-31 | $37,882 |
| 2014-12-31 | $37,916 |
| 2014-09-30 | $38,005 |
| 2014-06-30 | $38,032 |
| 2014-03-31 | $38,125 |
| 2013-12-31 | $36,071 |
| 2013-09-30 | $36,137 |
| 2013-06-30 | $36,211 |
| 2013-03-31 | $36,313 |
| 2012-12-31 | $36,148 |
| 2012-09-30 | $36,223 |
| 2012-06-30 | $36,316 |
| 2012-03-31 | $36,230 |
| 2011-12-31 | $36,327 |
| 2011-09-30 | $36,453 |
| 2011-06-30 | $36,719 |
| 2011-03-31 | $35,358 |
| 2010-12-31 | $35,453 |
| 2010-09-30 | $35,549 |
| 2010-06-30 | $35,621 |
| 2010-03-31 | $35,711 |
| 2009-12-31 | $35,807 |
| 2009-09-30 | $35,826 |
| 2009-06-30 | $35,781 |
| 2009-03-31 | $35,857 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $76.787B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.278B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Revvity (RVTY) | United States | $12.220B | 21.03 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.73 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |